A Single Ascending Dose Study of JNJ-88260237 in Healthy Participants
Clinical trial NCT05541315 · COMPLETED
Trial details
- NCT number
- NCT05541315
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2023-05-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.